Content(per 1 capsule): peptide complex A-21 (peptide of parathyroids), microcrystalline cellulose (E460, the flowing agent), gelatin (encapsulating agent), sugar beet (binding filler), lactose (excipient-humectant), starch (stabilizer), tween-80 (emulsifier), titanium dioxide (E171, coloring agent for capsules).
Dossage: Adults 1-2 capsules 1-2 times daily with meals.
These peptides have a selective action on cells of parathyroid, they normalize metabolism and also improve their functional activity. Clinical studies showed the effectiveness of Bonothyrk for restoration of functional activity parathyroid in cases of impairment various genesis, including during hyperparathyroidism, including osteoporosis, deossification, urolithiasis, muscle weakness, and also hypocalcemia, numbness and muscle spasms.
FDA Canadian and USA Disclaimer
This Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.